| Disease | hypophosphatemia |
| Phenotype | C0022658|renal disease |
| Sentences | 1 |
| PubMedID- 23992043 | Aim: to assess the effect and safety of lanthanum carbonate (lc) for hypophosphatemia in patients with end-stage renal disease (esrd). |
Page: 1